glycine and rifampin
glycine has been researched along with rifampin in 11 studies
Research
Studies (11)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Umbarger, HE; Vonder Haar, RA | 1 |
| Midgley, JE; Smith, RJ | 4 |
| Majtán, V; Miko, M | 1 |
| De Man, H; De Vos, F; Dumolyn, C; Huisman, MT; Mannens, G; Moerman, L; Neyt, S; Vanhove, C; Vliegen, M | 1 |
| Bessudo, A; Esseltine, DL; Gupta, N; Hanley, MJ; Ke, A; Liu, G; Nemunaitis, J; O'Neil, BH; Patel, C; Rasco, DW; Rowland Yeo, K; Sharma, S; Venkatakrishnan, K; Wang, B; Xia, C; Zhang, X | 1 |
| Fan, B; Ke, A; Le, K; Prakash, C; Yang, H | 1 |
Trials
1 trial(s) available for glycine and rifampin
| Article | Year |
|---|---|
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Ana
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Boron Compounds; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Glycine; Humans; Ketoconazole; Male; Middle Aged; Models, Biological; Neoplasms; Proteasome Inhibitors; Rifampin | 2018 |
Other Studies
10 other study(ies) available for glycine and rifampin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Isoleucine and valine metabolism in Escherichia coli. XIX. Inhibition of isoleucine biosynthesis by glycyl-leucine.
Topics: Acylation; Cell-Free System; Chloramphenicol; Culture Media; Dipeptides; Drug Resistance, Microbial; Escherichia coli; Glycine; Hydro-Lyases; Isoleucine; Leucine; Lyases; Mutation; Operon; Pyruvates; Rifampin; Threonine; Valine | 1972 |
The effect of trimethoprim on macromolecular synthesis in Escherichia coli.
Topics: Adenine; Bacterial Proteins; Carbon Radioisotopes; Escherichia coli; Galactosidases; Glycine; Guanosine; Methionine; Peptide Chain Initiation, Translational; Purines; Rifampin; RNA, Bacterial; Trimethoprim; Tritium; Uracil | 1973 |
The effect of trimethoprim on macromolecular synthesis in Escherichia coli. Ribosome maturation in RCstr and RCrel strains.
Topics: Bacterial Proteins; Chromatography, Ion Exchange; Escherichia coli; Glycine; Methionine; Peptide Chain Initiation, Translational; Purines; Puromycin; Ribosomes; Rifampin; RNA, Bacterial; RNA, Ribosomal; Trimethoprim; Tritium; Uracil | 1973 |
The effect of trimethoprim on macromolecular synthesis in Escherichia coli. Regulation of ribonucleic acid synthesis by 'Magic Spot' nucleotides.
Topics: Centrifugation, Density Gradient; Escherichia coli; Glycine; Guanine Nucleotides; Methionine; Nucleotides; Phosphorus Radioisotopes; Purines; Rifampin; RNA, Bacterial; Thymine; Time Factors; Trimethoprim; Valine | 1973 |
The control of ribonucleic acid synthesis in bacteria. Fluctuations in messenger ribonucleic acid synthesis in cultures recovering from amino acid starvation.
Topics: Amino Acids; Carbon Radioisotopes; Escherichia coli; Glycine; Kinetics; Methionine; Mutation; Protein Biosynthesis; Rifampin; RNA, Bacterial; RNA, Messenger; Time Factors; Transcription, Genetic; Trimethoprim; Tritium; Tyrosine; Uracil | 1974 |
The effect of rifampicin on Mycobacterium smegmatis.
Topics: Adenine; Bacterial Proteins; DNA, Bacterial; Glycine; Leucine; Mycobacterium; Oxygen Consumption; Rifampin; RNA, Bacterial | 1982 |
In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.
Topics: Aniline Compounds; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Ducts; Biological Transport; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Female; Glycine; Imino Acids; Ligation; Liver; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Organic Cation Transporter 1; Organotechnetium Compounds; Rifampin; Tomography, Emission-Computed, Single-Photon | 2013 |
Physiologically based pharmacokinetic modeling and simulation to predict drug-drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia.
Topics: Administration, Oral; Antineoplastic Agents; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Glycine; Healthy Volunteers; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Male; Microsomes, Liver; Models, Biological; Pyridines; Rifampin | 2020 |